English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/216237
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Mode of action of a formulation containing hydrazones and saponins against leishmania spp. Role in mitochondria, proteases and reinfection process

AuthorsUpegui, Yulieth A.; Echeverri, Fernando; Quiñones, Winston; Torres, Fernando; Nácher-Vázquez, Montserrat ; Rivas, Luis ; dos Santos Meira, Camila; Gedamu, Lashitew; Escobar, Gustavo; Archbold, Rosendo; Vélez, Ivan D.; Robledo, Sara M.
KeywordsChromane hydrazone
Leishmania braziliensis
L. pifanoi
Sapindus saponaria
ATP level
Mitochondria
Proteases
Morphology
Reinfection process
Issue Date26-Jun-2020
PublisherElsevier
CitationInternational Journal for Parasitology: Drugs and Drug Resistance 13: 94-106 (2020)
AbstractToxicity and poor adherence to treatment that favors the generation of resistance in the Leishmania parasites highlight the need to develop better alternatives. Here, we evaluated the in vitro effectiveness of hydrazone derived from chromanes 2-(2,3-dihydro-4H-1-benzothiopyran-4-ylidene) hydrazide (TC1) and 2-(2,3-dihydro- 4H-1-benzopyran-4-ylidene) hydrazide (TC2) and the mixture of triterpene saponin hederagenin-3-O-(3,4-Odiacetyl-ß-D-xylopyranosyl-(1à3)-a-L- rhamnopyranosyl-(1à2)-a-L-arabinofuranoside, hederagenin-3-O-(3,4-Odiacetyl-a-L- arabinopyranosyl-(1à3)-a-L-rhamnopyranosyl-(1à2)-a-L-arabinofuranoside and, hederagenin-3-O-(4-O-acetyl-ß-D-xylopyranosyl-(1à3)-a-L-rhamnopyranosyl-(1à2)-a-L-arabinofuranoside from Sapindus saponaria(SS) on L. braziliensis and L. pifanoi. Mixtures of TC1 or TC2 with saponin were formulated for topical application and the therapeutic effectiveness was evaluated in the model for cutaneous leishmaniasis (CL) in golden hamster.The mode of action of these compounds was tested on various parasite processes and ultrastructural parasite modifications. TC1, TC2 and SS showed moderate cytotoxicity when tested independently but toxicity was improved when tested in combination. The compounds were more active against intracellular Leishmania amastigotes. In vivo studies showed that combinations of TC1 or TC2 with SS in 1:1 ratio (w/w) cured 100% of hamsters with no signs associated with toxicity. The compounds did cause changes in the mitochondrial activity of the parasite with a decrease in ATP levels and depolarization of membrane potential and overproduction of reactive oxygen species; nevertheless, these effects were not related to alterations in membrane permeability.The phagolysosome ultrastructure was also affected impacting the survival of Leishmania but the function of the lysosome nor the pH inside the phagolysosome did not change.Lastly, there was a protease inhibition which was directly related to the decrease in the ability of Leishmania to infect and multiply inside the macrophage. The results suggest that the combination of TC1 and TC2 with SS in a 1:1 ratio is capable of curing CL in hamsters.This effect may be due to the ability of these compounds to affect parasite survival and the ability to infect new cells.
Description13 p.-8 fig.-3 tab.
Publisher version (URL)https://doi.org/10.1016/j.ijpddr.2020.06.004
URIhttp://hdl.handle.net/10261/216237
DOI10.1016/j.ijpddr.2020.06.004
E-ISSN2211-3207
Appears in Collections:(CIB) Artículos
Files in This Item:
File Description SizeFormat 
International Journal for Parasitology Drugs and Drug Resistance_ Upegui Zapata_2020.pdfArtículo principal2,71 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.